학술논문

Idelalisib (PI3Kδ inhibitor) therapy for patients with relapsed/refractory chronic lymphocytic leukemia: A Swedish nation-wide real-world report on consecutively identified patients
Document Type
Artikel
Source
European journal of haematology. 111(5):715-721
Subject
Medicin och hälsovetenskap
Language
English
English
ISSN
1600-0609